(PDF) Pcn355 - Utility in French Health-Economic Opinions:

Pcn355 - Utility in French Health-Economic Opinions: Key Learnings of a Retrospective Analysis in Oncology Drugs

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.437

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Prm112 - Incorporation of Anti-Cancer Drugs Adverse Events in Health Economic Opinions of the French National Authority for Health (Has)

Value in Health

Occupational Health

English

Ht7 - A Review of Efficiency Opinions of French ‘Haute Autorite De Sante’ (Has) in the Oncology Field

Value in Health

Occupational Health

English

Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?

Value in Health

Occupational Health

English

Reimbursement Decisions in Oncology Drugs: An International Analysis

Value in Health

Occupational Health

English

Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs

Value in Health

Occupational Health

English

Use of Budget Impact Analysis (Bia) in Economic Evaluations of Drugs and Medical Devices Submitted to the French National Authority for Health (Has)

Value in Health

Occupational Health

English

Health and Economic Impact of Routine Pediatric Pneumococcal Immunization Programs in Canada: A Retrospective Analysis

Infectious Diseases and Therapy

Infectious Diseases

English

Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology

JAMA - Journal of the American Medical Association

English

Learnings From Pilot Implementation of Smart City by a Brazilian Energy Utility

English